Correction to: Monoclonal anti‑CGRP antibodies in post‑menopausal women: a real‑life study

被引：0
|
作者：
Simona Guerzoni
Carlo Baraldi
Daria Brovia
Maria Michela Cainazzo
Flavia Lo Castro
Luca Pani
机构：
[1] AOU Policlinico di Modena,Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology
[2] University of Modena and Reggio Emilia,Headache Center and Drug Abuse
[3] University of Modena and Reggio Emilia,Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines
[4] University of Modena and Reggio Emilia,PhD School in Neurosciences, Department of Biomedical, Metabolic and Neural Sciences
[5] University of Miami,Post
[6] VeraSci,Graduate School in Pharmacology, Department of Biomedical, Metabolic and Neural Sciences
来源：
Acta Neurologica Belgica | 2023年 / 123卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2075 / 2075
相关论文
共 50 条
  • [41] Anti-CGRP monoclonal antibodies and peripheral sensitization: a study on Pressure Pain Threshold in migraineurs
    Garascia, G.
    Deodato, M.
    D'Acunto, L.
    Granato, A.
    Biaduzzini, F.
    Manganotti, P.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [42] Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
    Vikelis, Michail
    Rikos, Dimitrios
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Andreou, Anna P.
    Russo, Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2025,
  • [43] Real-world evidence for frequency of constipation with the use of anti-CGRP monoclonal antibodies in chronic migraine
    Uzun, S.
    Frejvall, U.
    Sahin, G. Ozkaya
    Sahin, G.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [44] Algorithm for preventing migraine through anti-CGRP monoclonal antibodies: a guide for real-world practice
    Peres, Mario
    Gama, Reinilza
    CEPHALALGIA, 2019, 39 : 271 - 271
  • [45] Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Caronna, Edoardo
    Gallardo, Victor Jose
    Egeo, Gabriella
    Vazquez, Manuel Millan
    Castellanos, Candela Nieves
    Membrilla, Javier A.
    Vaghi, Gloria
    Rodriguez-Montolio, Joana
    Fabra, Neus Fabregat
    Sanchez-Caballero, Francisco
    Sanchez, Alex Jaimes
    Munoz-Vendrell, Albert
    Oliveira, Renato
    Garate, Gabriel
    Gonzalez-Osorio, Yesica
    Guisado-Alonso, Daniel
    Ornello, Raffaele
    Thunstedt, Cem
    Fernandez-Lazaro, Iris
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Torelli, Paola
    Aurilia, Cinzia
    Pere, Raquel Lamas
    Castrillo, Maria Jose Ruiz
    De Icco, Roberto
    Sances, Grazia
    Broadhurst, Sarah
    Ong, Hui Ching
    Garcia, Andrea Gomez
    Campoy, Sergio
    Sanahuja, Jordi
    Cabral, Goncalo
    Blasco, Isabel Beltran
    Waliszewska-Prosol, Marta
    Pereira, Liliana
    Layos-Romero, Almudena
    Luzeiro, Isabel
    Dorado, Laura
    Escudero, Maria Rocio Alvarez
    May, Arne
    Lopez-Bravo, Alba
    Martins, Isabel Pavao
    Sundal, Christina
    Irimia, Pablo
    Ros, Alberto Lozano
    Gago-Veiga, Ana Beatriz
    Juanes, Fernando Velasco
    Ruscheweyh, Ruth
    Sacco, Simona
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (10): : 927 - 937
  • [46] Effectiveness and tolerability of CGRP monoclonal antibodies in combination with monoclonal antibodies for other diseases: a multicenter study
    Pistoia, F.
    Iannone, L. F.
    Russo, A.
    Saporito, G.
    Ornello, R.
    De Santis, F.
    Albanese, M.
    Tassorelli, C.
    Guerzoni, S.
    Sances, G.
    Vaghi, G.
    Casalena, A.
    Dalla Volta, G.
    Mampreso, E.
    Valente, M.
    Geppetti, P.
    Sacco, S.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [47] Efficacy, safety and tolerability of monoclonal antibodies to CGRP in patients aged >65 years: a multicenter, prospective, real-life study
    Egeo, Gabriella
    Aurilia, Cinzia
    d'Onofrio, Florindo
    Frediani, Fabio
    Messina, Roberta
    Filippi, Massimo
    Querzani, Pietro
    Autunno, Massimo
    Cevoli, Sabina
    Proietti, Stefania
    Bonassi, Stefano
    Torelli, Paola
    Barbanti, Piero
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 80 - 81
  • [48] Lifestyles and quality of life of post menopausal women
    Lopez-Alegria, Fanny
    Soares De Lorenzi, Dino Roberto
    REVISTA MEDICA DE CHILE, 2011, 139 (05) : 618 - 624
  • [49] Predictors of ≥50% and ≥75% response to anti-CGRP monoclonal antibodies for migraine prevention in real life: results from a european multicenter observational study including 5818 patients
    Caronna, E.
    Gallardo, V. J.
    Alpuente, A.
    Torres-Ferrus, M.
    Huerta Villanueva, M.
    Munoz-Vendrell, A.
    Campoy Diaz, S.
    Obach Baurier, V.
    Fabregat Fabra, N.
    Gago-Viega, A.
    Sanchez Soblechero, A.
    Lozano Ros, A.
    Diaz de Teran, J.
    Membrilla Lopez, J. A.
    Rodriguez-Vico, J. S.
    Guerrero Peral, A. L.
    Garcia Azorin, D.
    Pascual, J.
    Garate, G.
    Cuadrado Godia, E.
    Dorado, L.
    Sanahuja, J.
    Echeverria Urabayen, A.
    Irimia Sieira, P.
    Sanchez del Rio, M.
    Lopez-Bravo, A.
    Alvarez Escudero, R.
    Velasco Juanes, F.
    Santos Lasaosa, S.
    Diaz Insa, S.
    Layos-Romero, A.
    Andres Lopez, A.
    Viguera Romero, J.
    Beltran Blasco, I.
    Gonzalez Oria, C.
    Zapata, S.
    Flores Pina, B.
    Fernandez Lazaro, I.
    Quintas Gutierrez, S.
    Gonzalez Martinez, A.
    Jaimes Sanchez, A.
    Garcia Gomez, A.
    Gonzalez Osorio, Y.
    Gonzalez-Quintanilla, V.
    Kortazar Zubizarreta, I.
    Manera Zorrilla-Lequerica, P.
    Miro Munoz, I.
    Guisado-Alonso, D.
    Oterino Duran, A.
    Riesco Perez, N.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [50] Partial and nonresponders to onabotulinumtoxinA can benefit from anti-CGRP monoclonal antibodies preventive treatment: A real-world evidence study
    Alpuente, Alicia
    Gallardo, Victor J.
    Caronna, Edoardo
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (07) : 2378 - 2382
12345